Steroidomic Changes in the Cerebrospinal Fluid of Women with Multiple Sclerosis
Authors:
- Radmila KanchevaRKRadmila Kancheva
- Eva Kubala HavrdováEHEva Kubala Havrdová
- Marta VelíkováMVMarta Velíková
- Ludmila KanchevaLKLudmila Kancheva
- Josef VčelákJVJosef Včelák
- Radek AmpapaRARadek Ampapa
- Michal ŽidóMŽMichal Židó
- Ivana ŠtětkářováIŠIvana Štětkářová
- Tereza ŠkodováTŠTereza Škodová
- Martin HillMartin Hill
Open Access
- 19 June 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (12) , 5904
Abstract
Multiple sclerosis (MS) is a long-term disease that causes inflammation and damage to the nervous system. This study evaluated steroidomic alterations related to MS in 57 female MS patients during the follicular phase and 17 during the luteal phase, as well as in age- and phase-matched controls. The data showed that (1) unconjugated and conjugated steroids were strongly linked between the blood and CSF. (2) MS patients have lower levels of unconjugated steroids compared to controls. However, unchanged levels of conjugated steroids suggest a possible increase in steroid sulfotransferase functioning. (3) MS patients show altered levels of steroids linked to 11β-hydroxylase (CYP11B1) function. While direct enzyme activity was not measured, disrupted cortisol biosynthesis—potentially linked to reduced functioning of both CYP11B1 and 17α-hydroxylase/17,20-lyase—is associated with more severe cases of MS. (4) Reduced levels of 5α/β-steroids and protective GABAergic 3α-hydroxy-5α/β-steroids in MS patients might be linked to the pathophysiology of MS. (5) A potential increase in AKR1C3 function in MS could contribute to inflammation, as this enzyme catalyzes the synthesis of both steroids and prostaglandins. However, direct measurements of enzyme activity are needed to confirm this hypothesis. (6) Lower pregnenolone levels in MS patients might weaken neuroprotection, while higher pregnenolone sulfate levels could support cognitive function. (7) Lower levels of protective pregnenolone, DHEA, and androstenediol were associated with worse MS, suggesting these steroids may help shield against the disease.Keywords
All Related Versions
Funding Information
- Czech Research Health Council (NU20-04-00450)
This publication has 41 references indexed in Scilit:
- Glucocorticoids and cognitive function: a walkthrough in endogenous and exogenous alterationsJournal of Endocrinological Investigation, 2023
- The role of sex hormones in women with multiple sclerosis: From puberty to assisted reproductive techniquesFrontiers in Neuroendocrinology, 2020
- Cortisol and DHEA in development and psychopathologyHormones and Behavior, 2017
- Gender differences in autoimmune diseaseFrontiers in Neuroendocrinology, 2014
- Dehydroepiandrosterone modulates T-cell response after major abdominal surgeryJournal of Surgical Research, 2014
- Assessment of steroidogenesis and steroidogenic enzyme functionsThe Journal of Steroid Biochemistry and Molecular Biology, 2013
- Estrogen augmentation in schizophrenia: A quantitative review of current evidenceSchizophrenia Research, 2012
- Peripheral neuroactive steroids may be as good as the steroids in the cerebrospinal fluid for the diagnostics of CNS disturbancesThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis ratsJournal of Neuroimmunology, 2009
- Amelioration of murine antigen-induced arthritis by dehydroepiandrosterone (DHEA)Inflammation Research, 2004